Literature DB >> 35170043

Surviving sepsis campaign: International guidelines for management of sepsis and septic shock in adults 2021 - endorsement by the Scandinavian society of anaesthesiology and intensive care medicine.

Marius Rehn1,2,3, Michelle S Chew4, Klaus T Olkkola5, Martin Ingi Sigurðsson6,7, Arvi Yli-Hankala8,9, Morten Hylander Møller10,11.   

Abstract

The Clinical Practice Committee of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine endorses the clinical practice guideline Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. The guideline serves as a useful bedside decision aid for clinicians managing adults with suspected and confirmed septic shock and sepsis-associated organ dysfunction.
© 2022 The Authors. Acta Anaesthesiologica Scandinavica published by John Wiley & Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation.

Entities:  

Keywords:  AGREE II; adults; clinical practice guideline; sepsis; septic shock

Mesh:

Year:  2022        PMID: 35170043      PMCID: PMC9310818          DOI: 10.1111/aas.14045

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.274


BACKGROUND

Sepsis and septic shock remain a leading global cause of mortality and morbidity. , , Anaesthesiologists and intensivists are regularly involved in the identification, resuscitation and management of adults with sepsis and septic shock. In November 2021, the Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 was published. The Clinical Practice Committee (CPC) of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine (SSAI) decided to appraise this guideline for possible endorsement to guide Scandinavian anaesthesiologists and intensivists in the identification, resuscitation, and management of adults with sepsis and septic shock.

METHODS

The SSAI CPC assessed the guideline using the Appraisal of Guidelines for REsearch and Evaluation (AGREE) II tool, as per the outlined process for endorsement of non‐SSAI guidelines.

RESULTS

Five SSAI CPC members completed the appraisal. One member co‐authored the guideline and was excluded from the evaluation, as per the SSAI endorsement process. The individual domain totals were: 1) scope and purpose 89%; 2) stakeholder involvement 92%; 3) rigor of development 81%; 4) clarity of presentation 89%; 5) applicability 73%; 6) editorial independence 85%; 7) overall assessment 87% (Figure 1).
FIGURE 1

Summary of the Appraisal of Guidelines for REsearch and Evaluation (AGREE) II assessment

Summary of the Appraisal of Guidelines for REsearch and Evaluation (AGREE) II assessment The breakdown of the individual appraisers (de‐identified) is available in the Supplementary Material.

DISCUSSION

This clinical practice guideline on the management of sepsis and septic shock in adults received overall high ratings on all domains with an acceptable agreement between the SSAI CPC appraisers. We believe this guideline can serve as a useful bedside decision aid for clinicians managing adults with suspected and confirmed sepsis and septic shock.

CONCLUSION

The SSAI CPC endorses the clinical practice guideline the Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.

DISCLOSURE OF INTEREST

No Clinical Practice Committee member had direct conflicts of interest. MHM was a co‐author of the guideline assessed and did not participate in the AGREE II assessment, as per the SSAI endorsement process. No other authors had indirect conflicts of interest. Supplementary Material Click here for additional data file.
  7 in total

Review 1.  AGREE II: advancing guideline development, reporting and evaluation in health care.

Authors:  Melissa C Brouwers; Michelle E Kho; George P Browman; Jako S Burgers; Francoise Cluzeau; Gene Feder; Béatrice Fervers; Ian D Graham; Jeremy Grimshaw; Steven E Hanna; Peter Littlejohns; Julie Makarski; Louise Zitzelsberger
Journal:  CMAJ       Date:  2010-07-05       Impact factor: 8.262

Review 2.  Endorsement of clinical practice guidelines by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine.

Authors:  Marius Rehn; Michelle S Chew; Klaus T Olkkola; Kristinn Örn Sverrison; Arvi Yli-Hankala; Morten Hylander Møller
Journal:  Acta Anaesthesiol Scand       Date:  2018-12-03       Impact factor: 2.105

3.  Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.

Authors:  Laura Evans; Andrew Rhodes; Waleed Alhazzani; Massimo Antonelli; Craig M Coopersmith; Craig French; Flávia R Machado; Lauralyn Mcintyre; Marlies Ostermann; Hallie C Prescott; Christa Schorr; Steven Simpson; W Joost Wiersinga; Fayez Alshamsi; Derek C Angus; Yaseen Arabi; Luciano Azevedo; Richard Beale; Gregory Beilman; Emilie Belley-Cote; Lisa Burry; Maurizio Cecconi; John Centofanti; Angel Coz Yataco; Jan De Waele; R Phillip Dellinger; Kent Doi; Bin Du; Elisa Estenssoro; Ricard Ferrer; Charles Gomersall; Carol Hodgson; Morten Hylander Møller; Theodore Iwashyna; Shevin Jacob; Ruth Kleinpell; Michael Klompas; Younsuck Koh; Anand Kumar; Arthur Kwizera; Suzana Lobo; Henry Masur; Steven McGloughlin; Sangeeta Mehta; Yatin Mehta; Mervyn Mer; Mark Nunnally; Simon Oczkowski; Tiffany Osborn; Elizabeth Papathanassoglou; Anders Perner; Michael Puskarich; Jason Roberts; William Schweickert; Maureen Seckel; Jonathan Sevransky; Charles L Sprung; Tobias Welte; Janice Zimmerman; Mitchell Levy
Journal:  Intensive Care Med       Date:  2021-10-02       Impact factor: 17.440

4.  Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014.

Authors:  Chanu Rhee; Raymund Dantes; Lauren Epstein; David J Murphy; Christopher W Seymour; Theodore J Iwashyna; Sameer S Kadri; Derek C Angus; Robert L Danner; Anthony E Fiore; John A Jernigan; Greg S Martin; Edward Septimus; David K Warren; Anita Karcz; Christina Chan; John T Menchaca; Rui Wang; Susan Gruber; Michael Klompas
Journal:  JAMA       Date:  2017-10-03       Impact factor: 56.272

5.  Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations.

Authors:  Carolin Fleischmann; André Scherag; Neill K J Adhikari; Christiane S Hartog; Thomas Tsaganos; Peter Schlattmann; Derek C Angus; Konrad Reinhart
Journal:  Am J Respir Crit Care Med       Date:  2016-02-01       Impact factor: 21.405

Review 6.  Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis.

Authors:  C Fleischmann-Struzek; L Mellhammar; N Rose; A Cassini; K E Rudd; P Schlattmann; B Allegranzi; K Reinhart
Journal:  Intensive Care Med       Date:  2020-06-22       Impact factor: 17.440

Review 7.  Surviving sepsis campaign: International guidelines for management of sepsis and septic shock in adults 2021 - endorsement by the Scandinavian society of anaesthesiology and intensive care medicine.

Authors:  Marius Rehn; Michelle S Chew; Klaus T Olkkola; Martin Ingi Sigurðsson; Arvi Yli-Hankala; Morten Hylander Møller
Journal:  Acta Anaesthesiol Scand       Date:  2022-03-06       Impact factor: 2.274

  7 in total
  3 in total

Review 1.  Surviving sepsis campaign: International guidelines for management of sepsis and septic shock in adults 2021 - endorsement by the Scandinavian society of anaesthesiology and intensive care medicine.

Authors:  Marius Rehn; Michelle S Chew; Klaus T Olkkola; Martin Ingi Sigurðsson; Arvi Yli-Hankala; Morten Hylander Møller
Journal:  Acta Anaesthesiol Scand       Date:  2022-03-06       Impact factor: 2.274

2.  Therapeutic Effect of Continuous Blood Purification Combined with Humanized Nursing in Patients with Severe Sepsis.

Authors:  Lili Gan; Jiafeng Hu; Li Xia; Xiaoqin Xi
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-16       Impact factor: 2.650

3.  Early antibiotic therapy is associated with a lower probability of successful liberation from mechanical ventilation in patients with severe acute exacerbation of chronic obstructive pulmonary disease.

Authors:  G Deniel; M Cour; L Argaud; J C Richard; L Bitker
Journal:  Ann Intensive Care       Date:  2022-09-24       Impact factor: 10.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.